1. Home
  2. BTQ vs AUTL Comparison

BTQ vs AUTL Comparison

Compare BTQ & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTQ

BTQ Technologies Corp.

N/A

Current Price

$3.42

Market Cap

452.3M

Sector

N/A

ML Signal

N/A

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

HOLD

Current Price

$1.65

Market Cap

431.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTQ
AUTL
Founded
1983
2014
Country
Canada
United Kingdom
Employees
27
647
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
452.3M
431.2M
IPO Year
N/A
2025

Fundamental Metrics

Financial Performance
Metric
BTQ
AUTL
Price
$3.42
$1.65
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
4
Target Price
$10.00
$8.50
AVG Volume (30 Days)
2.2M
1.4M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.33
EPS
N/A
N/A
Revenue
N/A
$10,120,000.00
Revenue This Year
$100.70
$670.78
Revenue Next Year
$669.96
$80.13
P/E Ratio
N/A
N/A
Revenue Growth
N/A
496.00
52 Week Low
$2.28
$1.11
52 Week High
$16.00
$2.70

Technical Indicators

Market Signals
Indicator
BTQ
AUTL
Relative Strength Index (RSI) 49.50 53.15
Support Level $2.30 $1.27
Resistance Level $3.37 $1.74
Average True Range (ATR) 0.30 0.11
MACD 0.17 0.01
Stochastic Oscillator 67.88 46.95

Price Performance

Historical Comparison
BTQ
AUTL

About BTQ BTQ Technologies Corp.

BTQ Technologies Corp is engaged in the development of computer-based technology related to post-quantum cryptography, particularly as it applies to blockchain and related technologies, and their protection from the emerging security risk of quantum computing. Its products include PQScale, Keelung, Kenting, and Qbyte. PQScale is a novel scaling technique for post-quantum cryptographic primitives. Keelung is a zero-knowledge toolkit for fast, private, and secure applications. Kenting provides acceleration for NIST-compliant post-quantum cryptography, post-quantum zk-SNARKs, and eco-friendly mining hardware, and Qbyte is a quantum risk calculator. Geographically, the company derives maximum revenue from Canada, and also has a presence in Taiwan, and Australia.

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Share on Social Networks: